Abstract
Hepatitis C carries a large burden of disease in Canada. Barriers to care, especially in the incarcerated population, may impede effective treatment and the achievement of targets for disease eradication. Access to universal screening in incarcerated populations could support engagement in the care cascade, and local studies around prevalence and screening efficacy could be used to justify and inform screening programs. A focus on incarcerated populations is an important step toward HCV eradication and ensuring equitable healthcare for all. This article will discuss the HCV care cascade, the unique burden of HCV in correctional facilities, and provide an argument in support of universal screening in incarcerated populations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
